199 related articles for article (PubMed ID: 2395109)
1. Inhibition of rat liver estrogen 2/4-hydroxylase activity by troleandomycin: comparison with erythromycin and roxithromycin.
Fisher D; Labbe G; Berson A; Tinel M; Loeper J; Larrey D; Pessayre D
J Pharmacol Exp Ther; 1990 Sep; 254(3):1120-7. PubMed ID: 2395109
[TBL] [Abstract][Full Text] [Related]
2. Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides.
Tinel M; Descatoire V; Larrey D; Loeper J; Labbe G; Letteron P; Pessayre D
J Pharmacol Exp Ther; 1989 Aug; 250(2):746-51. PubMed ID: 2527301
[TBL] [Abstract][Full Text] [Related]
3. Comparative studies of in vitro inhibition of cytochrome P450 3A4-dependent testosterone 6beta-hydroxylation by roxithromycin and its metabolites, troleandomycin, and erythromycin.
Yamazaki H; Shimada T
Drug Metab Dispos; 1998 Nov; 26(11):1053-7. PubMed ID: 9806945
[TBL] [Abstract][Full Text] [Related]
4. Formation in vitro of an inhibitory cytochrome P450 x Fe2+-metabolite complex with roxithromycin and its decladinosyl, O-dealkyl and N-demethyl metabolites in rat liver microsomes.
Yamazaki H; Shimada T
Xenobiotica; 1998 Oct; 28(10):995-1004. PubMed ID: 9849646
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of cytochrome P-450 by a troleandomycin metabolite. Protective role of glutathione.
Pessayre D; Tinel M; Larrey D; Cobert B; Funck-Brentano C; Babany G
J Pharmacol Exp Ther; 1983 Mar; 224(3):685-91. PubMed ID: 6600790
[TBL] [Abstract][Full Text] [Related]
6. Effects of erythromycin and roxithromycin on oxidation of testosterone and nifedipine catalyzed by CYP3A4 in human liver microsomes.
Yamazaki H; Urano T; Hiroki S; Shimada T
J Toxicol Sci; 1996 Nov; 21(4):215-26. PubMed ID: 8959645
[TBL] [Abstract][Full Text] [Related]
7. Imprinting of hepatic microsomal cytochrome P-450 enzyme activities and cytochrome P-450IIC11 by peripubertal administration of testosterone in female rats.
Cadario BJ; Bellward GD; Bandiera S; Chang TK; Ko WW; Lemieux E; Pak RC
Mol Pharmacol; 1992 May; 41(5):981-8. PubMed ID: 1588929
[TBL] [Abstract][Full Text] [Related]
8. Effects of roxithromycin, erythromycin and troleandomycin on their N-demethylation by rat and human cytochrome P450 enzymes.
Yamazaki H; Hiroki S; Urano T; Inoue K; Shimada T
Xenobiotica; 1996 Nov; 26(11):1143-53. PubMed ID: 8948090
[TBL] [Abstract][Full Text] [Related]
9. In vivo and in vitro effects of beta-naphthoflavone on cytochrome P-450-dependent testosterone hydroxylase activities in liver microsomes.
Shiverick KT
Drug Metab Dispos; 1981; 9(6):545-50. PubMed ID: 6120814
[TBL] [Abstract][Full Text] [Related]
10. Self-induction by erythromycin of its own transformation into a metabolite forming an inactive complex with reduced cytochrome P-450.
Danan G; Descatoire V; Pessayre D
J Pharmacol Exp Ther; 1981 Aug; 218(2):509-14. PubMed ID: 7252850
[TBL] [Abstract][Full Text] [Related]
11. Effects of clarithromycin and its metabolites on the mixed function oxidase system in hepatic microsomes of rats.
Ohmori S; Ishii I; Kuriya S; Taniguchi T; Rikihisa T; Hirose S; Kanakubo Y; Kitada M
Drug Metab Dispos; 1993; 21(2):358-63. PubMed ID: 8097709
[TBL] [Abstract][Full Text] [Related]
12. Complexation of cytochrome P-450 isozymes in hepatic microsomes from SKF 525-A-induced rats.
Murray M
Arch Biochem Biophys; 1988 May; 262(2):381-8. PubMed ID: 3364973
[TBL] [Abstract][Full Text] [Related]
13. Erythromycin as a specific substrate for cytochrome P4503A isozymes and identification of a high-affinity erythromycin N-demethylase in adult female rats.
Zhang XJ; Thomas PE
Drug Metab Dispos; 1996 Jan; 24(1):23-7. PubMed ID: 8825186
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo effects of the arylamine human immunodeficiency virus protease inhibitor 4R-(4alpha,5alpha,6beta, 7beta)-1-[(3-(1-imidazoylcarbamoyl)phenyl)methyl]-3-[(3-aminophenyl)m ethyl]hexahydro-5,6-dihydroxy-4,7-bis(phenylmethyl)-2H-1, 3-diazepin-2-one (SD894) on rat hepatic cytochrome P450 2B and 3A.
Grubb MF; Diamond S; Christ DD
Drug Metab Dispos; 1997 Dec; 25(12):1424-8. PubMed ID: 9394033
[TBL] [Abstract][Full Text] [Related]
15. In vitro formation of an inhibitory complex between an isosafrole metabolite and rat hepatic cytochrome P-450 PB-B.
Murray M; Reidy GF
Drug Metab Dispos; 1989; 17(4):449-54. PubMed ID: 2571488
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of oxidative drug metabolism by orphenadrine: in vitro and in vivo evidence for isozyme-specific complexation of cytochrome P-450 and inhibition kinetics.
Reidy GF; Mehta I; Murray M
Mol Pharmacol; 1989 May; 35(5):736-43. PubMed ID: 2725477
[TBL] [Abstract][Full Text] [Related]
17. Participation of P450 3A enzymes in rat hepatic microsomal retinoic acid 4-hydroxylation.
Martini R; Murray M
Arch Biochem Biophys; 1993 May; 303(1):57-66. PubMed ID: 8489266
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of rat hepatic microsomal cytochrome P-450. II. Effect of the in vitro administration of cimetidine.
Chang T; Levine M; Bellward GD
J Pharmacol Exp Ther; 1992 Mar; 260(3):1450-5. PubMed ID: 1545404
[TBL] [Abstract][Full Text] [Related]
20. Studies on the cytochrome P450 (CYP)-mediated metabolic properties of miocamycin: evaluation of the possibility of a metabolic intermediate complex formation with CYP, and identification of the human CYP isoforms.
Kasahara M; Suzuki H; Komiya I
Drug Metab Dispos; 2000 Apr; 28(4):409-17. PubMed ID: 10725309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
